6D6 is a cross-reactive GP-specific mAb. This mab recognizes the putative epitope in the highly conserved IFL and neutralizes infectivity of representative isolates of all known ebolavirus species by inhibiting the membrane fusion. MAb 6D6 was found to be GP-specific and to efficiently neutralize the infectivity of vesicular stomatitis virus (VSV) pseudotyped with GPs of all known ebolaviruses (EBOV, SUDV, TAFV, BDBV, and RESTV), including the variant that caused the latest outbreak in West Africa (EBOV2014), but not Marburg virus (MARV), a related filovirus that causes human disease similar to EVD.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
PABX-163 | Recombinant Mouse Anti-Glycoprotein Antibody (523-11) | WB, ELISA, Neut, FuncS | IgG |
PABX-163-F (E) | Recombinant Mouse Anti-Glycoprotein Antibody Fab Fragment (523-11) | WB, ELISA, Neut, FuncS | Fab |
There are currently no Customer reviews or questions for VS-0724-YC47. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.